Context: The response to treatment with vitamin D varies between patients.
Objective: To identify genetic variants associated with the biochemical response to vitamin D3 supplementation.
Design: Randomized placebo-controlled trial conducted between 2017 and 2019.
Setting: The trial was nested in an ongoing community-based cohort study, the Multi-Ethnic Study of Atherosclerosis (MESA).
Intervention: 2,000 International Units of vitamin D3 or placebo daily for 16 weeks.
Participants: The analytic sample included 427 participants assigned to vitamin D3 (mean age 73 y, 54% females) and was 36% White, 33% Black, 18% Hispanic, and 14% Chinese.
Main outcome measures: The biochemical response to vitamin D3 included changes in serum concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], parathyroid hormone (PTH), and 25-hydroxyvitamin D3 [25(OH)D3].
Results: In genome-wide analyses, SNPs in 8 regions of the genome had significant association (p < 5E-08) with one of the traits (2 with change in 1,25(OH)2D3, 1 with change in PTH, and 5 with change in 25(OH)D3). rs16867276 within an intergenic region on 2q31 was associated with change in serum 1,25(OH)2D3 (+8.37 pg/mL difference per effect allele; p = 4.93E-08) and was the only locus that achieved genome-wide significance in transethnic meta-analysis. rs114044709 adjacent to FAM20A, which encodes a protein required for biomineralization, was associated with change in PTH among Black participants (+20.32 pg/mL difference per effect allele; p = 1.34E-08). In candidate analyses, SNPs within SULT2A1 and CYP24A1 had significant association (p < 0.05 ÷ 36 = 0.0014) with the changes in 1,25(OH)2D3 and PTH, respectively.
Conclusions: Our results reveal potential new pathways of vitamin D regulation that require replication in other vitamin D trials.
Keywords: Clinical Trials; Nutrition; PTH/Vit D/FGF23; Pharmacogenomics.
© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. See the journal About page for additional terms.